Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Neurofibrosarcoma 1Neoplasms, Connective and Soft Tissue 1Myosarcoma 1Microsatellite Instability 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Histiocytoma 1Glioma 1Glioblastoma 1Fibrosarcoma 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Doxorubicin 2lentiviral minigene vaccine of COVID-19 coronavirus 1irinotecan sucrosofate 1brostallicin 1Vinorelbine 1Trabectedin 1Temozolomide 1Radiotherapy 1Cyclophosphamide 1Biological Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Rhabdomyosarcoma × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT01883518 2019-11-20

ADCVCTAST

N.N. Petrov National Medical Research Center of Oncology

Phase 1/2 Unknown
48 enrolled
Sarcoma

Chondrosarcoma, Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Myosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neoplasms, Connective and Soft Tissue, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡